Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy

Despite over 20 years of clinical use, IL-2 has not fulfilled expectations as a safe and effective form of tumour immunotherapy. Expression of the high affinity IL-2Rα chain on regulatory T cells mitigates the anti-tumour immune response and its expression on vascular endothelium is responsible for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemi, Reza, Lazear, Eric, Wang, Xiaoli, Arefanian, Saeed, Zheleznyak, Alexander, Carreno, Beatriz M., Higashikubo, Ryuji, Gelman, Andrew E., Kreisel, Daniel, Fremont, Daved H., Krupnick, Alexander Sasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036003/
https://www.ncbi.nlm.nih.gov/pubmed/27650575
http://dx.doi.org/10.1038/ncomms12878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036003/
https://www.ncbi.nlm.nih.gov/pubmed/27650575
http://dx.doi.org/10.1038/ncomms12878

Ejemplares similares